A8B-28464-08606
5 vaccinations
6 coded responses
37 check-ins
5 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 318 / GA
- Registered
- 2021-03-12
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-09
Dose 1 — Pfizer-BioNTech
-
2021-03-12
Registered in v-safe
- 2021-03-12
- 2021-03-13
- 2021-03-14
- 2021-03-16
- 2021-03-26
- 2021-03-30
-
2021-04-01
Dose 2 — Pfizer-BioNTech
-
2021-04-06
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Itching · Fever · Chills, Headache, Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-04-07
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activitiesAdult check-in
- 2021-04-10
- 2021-04-15
-
2021-04-24
Survey response — day 21, dose 2MedDRA: Headache — Feeling: Poor · Be unable to do your normal daily activitiesFree text: HeadachesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-30
Survey response — day 28, dose 2MedDRA: Dermatitis contact, Fatigue, Headache, Hypersensitivity, Pre-existing disease, Rash, Seasonal allergy — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Since vaccination I have unusual extreme sinus reaction to pollen with headaches. My left arm rash comes and goes. My allergic response to poison ivy is extreme and long lasting. I have heightened allergic responses and fatigue.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-08
- 2021-05-13
- 2021-07-03
- 2021-09-30
-
2021-11-11
Dose 3 — Pfizer-BioNTech
-
2022-04-02
Survey response — 12 months, dose 2MedDRA: Fatigue, Headache, Inflammation, Office visit, Ophthalmic migraine, Sinus congestion, Tooth disorder — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Symptoms: Inflammation. unexplained periodontal issues. Headaches and sinus congestion; more than usual. Fatigue. Occular migraines. · Healthcare visit (other): ENT, Periodontal specialist, Neurologist, Primary care ultrasound, ct scan, dental x-rayMedDRA releases: 2024-11 · check-in free text available
-
2022-04-02
Report sent to call center — 12 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-04-05
Call successfulDoes not wish to fill out VAERS report
-
2022-06-03
Dose 4 — Pfizer-BioNTech
-
2022-06-05
Survey response — days 1–6 daily, dose 4MedDRA: Insomnia, Pain — Feeling: Fair · Site: Pain, Itching · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Last night body aches and pain, couldn't sleepMedDRA releases: 2024-11 · check-in free text available
-
2022-06-06
Health check-in — days 1–6 daily, dose 4Feeling: Poor · Site: Pain · Fever · Headache · Be unable to do your normal daily activitiesAdult check-in
-
2022-06-08
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Headache, Joint pains · Be unable to do your normal daily activitiesAdult check-in
- 2022-06-09
- 2022-06-10
- 2022-06-20
- 2022-07-09
-
2022-07-17
Survey response — day 42, dose 4MedDRA: Dizziness, Office visit, Unevaluable event — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: Dizzy, gastrointestinal · Healthcare visit (other): Primary care, neurology, ENT, DentistMedDRA releases: 2024-11 · check-in free text available
-
2022-07-17
Report sent to call center — day 42, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
-
2022-07-18
Call successfulDoes not wish to fill out VAERS report
- 2022-09-07
-
2022-11-09
Dose 5 — Pfizer-BioNTech
- 2022-11-09
-
2022-11-10
Health check-in — days 1–6 daily, dose 5Feeling: Fair · Site: Pain · Headache, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activitiesAdult check-in
- 2022-11-12
- 2022-11-14
- 2022-11-16
- 2022-11-24
- 2022-12-05
- 2022-12-07
- 2022-12-14
- 2022-12-21
-
2023-05-13
Survey response — 6 months, dose 5MedDRA: Herpes zoster — Feeling: Good · Be unable to do your normal daily activitiesMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-09 | Pfizer-BioNTech | |
| 2 | 2021-04-01 | Pfizer-BioNTech | |
| 3 | 2021-11-11 | Pfizer-BioNTech | No |
| 4 | 2022-06-03 | Pfizer-BioNTech | No |
| 5 | 2022-11-09 | Pfizer-BioNTech | No |
Call center
2 call center cases
2 successful
Free text
Release 7 — day 21, dose 2
Symptoms: Headaches
Release 8 — day 28, dose 2
Symptoms: Since vaccination I have unusual extreme sinus reaction to pollen with headaches. My left arm rash comes and goes. My allergic response to poison ivy is extreme and long lasting. I have heightened allergic responses and fatigue.
Release 11 — 12 months, dose 2
Symptoms: Inflammation. unexplained periodontal issues. Headaches and sinus congestion; more than usual. Fatigue. Occular migraines.
Healthcare visit (other): ENT, Periodontal specialist, Neurologist, Primary care ultrasound, ct scan, dental x-ray
Release 11 — days 1–6 daily, dose 4
Systemic reaction (other): Last night body aches and pain, couldn't sleep
Release 12 — day 42, dose 4
Symptoms: Dizzy, gastrointestinal
Healthcare visit (other): Primary care, neurology, ENT, Dentist
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Dermatitis contact | ✓ | ✓ | ✓ |
| SD | Dizziness | · | · | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Herpes zoster | · | · | ✓ |
| SD | Hypersensitivity | ✓ | ✓ | ✓ |
| SD | Inflammation | · | · | ✓ |
| SD | Ophthalmic migraine | · | · | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
| SD | Rash | ✓ | ✓ | ✓ |
| SD | Seasonal allergy | ✓ | ✓ | ✓ |
| SD | Sinus congestion | · | · | ✓ |
| SD | Tooth disorder | · | · | ✓ |
| SD | Unevaluable event | · | · | ✓ |
| SRO | Insomnia | · | · | ✓ |
| SRO | Pain | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release